Clinical Trials on Severe Acute Respiratory Syndrome Coronavirus 2 in Peru
Total 20 results
-
CureVacGerman Federal Ministry of Education and ResearchCompletedSevere Acute Respiratory Syndrome | Covid19 | SARS-CoV-2 | CoronavirusPanama, Peru
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes...RecruitingInfluenza | Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) | Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)United States, Australia, Spain, Denmark, Greece, Argentina, United Kingdom, Belgium, Chile, Germany, Peru, Thailand
-
Universidad Peruana Cayetano HerediaBarcelona Institute for Global HealthCompletedCoronavirus Infection | Covid19 | SARS-CoV InfectionPeru
-
Hospital Nacional Carlos Alberto Seguin Escobedo...CompletedCovid19 | SARS-CoV Infection | TenofovirPeru
-
Sciwind Biosciences APAC CO Pty. Ltd.Hangzhou Sciwind Biosciences Co., Ltd.; Sciwind Biosciences USA Co., Ltd.WithdrawnCOVID-19 Acute Respiratory Distress SyndromeArgentina, Peru
-
Universidad Peruana Cayetano HerediaCompleted
-
GlaxoSmithKlineCompletedSevere Acute Respiratory SyndromeUnited States, Russian Federation, Peru, Netherlands, Spain, South Africa, United Kingdom, Argentina, Brazil, France, Canada, Mexico, Poland, Belgium, India, Japan, Chile, Colombia, Italy
-
Hospital Nacional Edgardo Rebagliati MartinsUniversidad de PiuraCompleted
-
Abbott NutritionTerminatedAcute Lung Injury | Respiratory Distress Syndrome,AdultRussian Federation
-
InflaRx GmbHCompletedSevere COVID-19 PneumoniaBelgium, Brazil, France, Germany, Mexico, Netherlands, Peru, Russian Federation, South Africa
-
NPO PetrovaxCompletedFibrosis | Lung Diseases, Interstitial | Lung; Disease, Interstitial, With Fibrosis | Post-Acute COVID-19 Syndrome | Lung Disease With PolymyositisRussian Federation
-
CureVacCompletedCovid19 | SARS-CoV-2Belgium, Spain, Germany, Argentina, Colombia, Dominican Republic, Mexico, Netherlands, Panama, Peru
-
HIV Vaccine Trials NetworkNational Institute of Allergy and Infectious Diseases (NIAID); HIV Prevention...CompletedCOVID-19 | SARS-CoV-2United States, Zimbabwe, Malawi, Peru, South Africa, Zambia
-
COVID-19 Prevention NetworkNational Institute of Allergy and Infectious Diseases (NIAID)CompletedCOVID-19 | SARS-CoV-2United States, Malawi, Zimbabwe, Botswana, South Africa, Zambia, Argentina, Brazil, Mexico, Peru, Tanzania
-
Al-Azhar UniversityHelwan University; National Liver Institute, EgyptCompletedCOVID-19 | Cholangiocarcinoma | SARS-CoV-2 | Pancreas Cancer | Obstructive Jaundice | Cholangitis, Secondary BiliarySingapore, Germany, United States, Egypt, Peru
-
National Cancer Institute (NCI)Active, not recruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Chronic Myelomonocytic Leukemia-1 | Chronic Myelomonocytic Leukemia-2 | Myelodysplastic Syndrome With Excess Blasts-1 | Myelodysplastic Syndrome/Acute Myeloid LeukemiaCanada, United States
-
AstraZenecaIqvia Pty LtdCompletedPhase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in AdultsCOVID-19 | SARS-CoV-2United States, Chile, Peru
-
Novartis PharmaceuticalsIncyte CorporationCompletedCytokine Storm (Covid-19)United States, Colombia, Turkey, Spain, United Kingdom, Germany, Peru, Russian Federation, Brazil, France, Mexico, Argentina
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolUnited States, Mexico, South Africa, Brazil, Chile, Colombia, Peru, Argentina
-
TakedaCompletedDiabetes Mellitus, Type 2 | Acute Coronary SyndromeUnited States, France, Italy, Poland, Ukraine, United Kingdom, Belgium, Germany, Hong Kong, Argentina, Chile, Colombia, Israel, Mexico, Portugal, Bulgaria, Malaysia, Romania, Serbia, South Africa, Japan, Canada, Finland, Taiwan, Korea,... and more